Patent · US Expired

Methods and uses of leptin in immune modulation

US8043619B2 · kind B2 · utility

3Cited by
1References
1Claims
0Family size

Inventors

Key dates

Filing dateOct 8, 2004
Grant dateOct 25, 2011
Priority date
Expiry dateJun 12, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/2264
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention describes the use of leptin for the immune modulation of the Th1/Th2 response. One aspect of the invention provides for a shift in the Th1/Th2 cell balance towards pro-inflammatory cytokine producing cells. This shift results from an increase in the levels, expression and/or the activity of leptin. Another aspect of the invention provides for a shift in the Th1/Th2 cell balance towards anti-inflammatory cytokine producing cells. This shift results from a decrease in the levels, expression and/or the activity of leptin. The shifting of the Th1/Th2 balance provides a method for the treatment of a variety of diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.